GO:0009059 macromolecule biosynthetic process: Biopolymer Synthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0009059 macromolecule biosynthetic process describes the chemical reactions and pathways that build macromolecules, which are high-molecular-mass molecules composed of repeated low-molecular-mass units.
• The term is a broad biological-process node that encompasses the synthesis of proteins, nucleic acids, polysaccharides, and other biopolymers, and it is annotated across bacteria, archaea, and eukaryotes.
• Macromolecule biosynthesis is not a single pathway but a functional category; its child terms include translation, DNA replication, RNA biosynthesis, and polysaccharide biosynthesis.
• Macromolecule-assisted de novo protein folding shows that biosynthetic products can themselves act as chaperone-like scaffolds, linking synthesis to quality control.
• Defects in macromolecule biosynthesis underlie diverse human conditions, including N-glycosylation deficiency, sarcopenia, and autism-spectrum-associated microbial macromolecule interactions [1,4,5].
• CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal dissection of genes annotated to macromolecule biosynthetic process.
Description
GO:0009059 macromolecule biosynthetic process is a Gene Ontology biological-process term that captures the chemical reactions and pathways resulting in the formation of a macromolecule, defined as any molecule of high relative molecular mass whose structure essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass. In practice, this term is a high-level node that groups together the biosynthesis of proteins, nucleic acids, polysaccharides, and other biopolymers, and it is used by annotators to describe gene products whose primary role is to build rather than degrade macromolecules. Because macromolecule biosynthesis consumes the majority of a cell's energy and precursor pools, its regulation is central to growth, proliferation, differentiation, and stress responses [4,7]. For researchers, GO:0009059 provides a functional lens for interpreting omics data. Enrichment of this term in a transcriptomic or proteomic experiment indicates that a biological system is actively investing in biopolymer production, whether that reflects ribosomal expansion during growth, extracellular matrix deposition during tissue remodeling, or microbial macromolecule interactions in a host environment [1,2,7]. The term is also mechanistically informative: macromolecule-assisted de novo protein folding demonstrates that newly synthesized polypeptides can be stabilized by macromolecular scaffolds, coupling biosynthesis directly to folding and quality control. This article synthesizes the QuickGO definition and verified PubMed literature to explain what happens during macromolecule biosynthetic process, which genes and proteins are involved, how the process is regulated, how it relates to human disease, and how CRISPR-based models and modern analytical methods can be used to study it [1,3,4,5,7,8].
macromolecule biosynthetic process At A Glance
| GO ID | GO:0009059 |
|---|---|
| GO term | macromolecule biosynthetic process |
| Ontology | biological_process |
| Synonym | biopolymer biosynthetic process; macromolecule anabolism; macromolecule biosynthesis; macromolecule formation; macromolecule synthesis |
| Major function | Chemical reactions and pathways resulting in the formation of macromolecules from low-molecular-mass units |
| Definition source | QuickGO definition, based on the Gene Ontology Consortium |
| Scope | Broad node encompassing protein, nucleic acid, polysaccharide, and other biopolymer biosynthesis |
| Representative child processes | Translation, DNA replication, RNA biosynthesis, polysaccharide biosynthesis |
| Organismal coverage | Annotated in bacteria, archaea, and eukaryotes |
What Is GO:0009059?
In our own words, GO:0009059 macromolecule biosynthetic process refers to the collection of enzymatic reactions and pathways that assemble macromolecules from smaller precursor units. A macromolecule is a molecule of high relative molecular mass whose structure is essentially built from the multiple repetition of units derived, actually or conceptually, from low-molecular-mass molecules. The term therefore covers anabolic processes such as protein translation, nucleic acid polymerization, and polysaccharide synthesis, and it is distinct from catabolic or degradation terms. It is a biological-process node in the Gene Ontology, with synonyms including biopolymer biosynthetic process, macromolecule anabolism, macromolecule biosynthesis, macromolecule formation, and macromolecule synthesis.
Why Is macromolecule biosynthetic process Important in Cell Biology?
Macromolecule biosynthetic process is important because it represents the core anabolic engine of every cell. It supplies the proteins, nucleic acids, and polysaccharides required for growth, division, structural integrity, and information storage, and its output determines how a cell responds to nutrients, stress, and developmental cues [4,7]. Because macromolecule biosynthesis is energetically expensive, its dysregulation is a hallmark of many pathological states, from metabolic and age-related decline to glycosylation disorders and host-microbe interactions in neurodevelopmental conditions [1,4,5]. Studying this term therefore connects fundamental biochemistry to translational questions in cancer, neurodegeneration, aging, and infection [1,3,4,5,7,8].
• Provides the proteins, nucleic acids, and polysaccharides needed for cell growth and division.
• Consumes a large fraction of cellular energy and precursor pools, making it a key node in metabolic regulation.
• Encompasses translation, DNA replication, RNA biosynthesis, and polysaccharide biosynthesis as child processes.
• Links biosynthesis to protein quality control through macromolecule-assisted de novo protein folding.
• Is implicated in N-glycosylation deficiency and congenital disorders of glycosylation.
• Is associated with age-related muscle decline and sarcopenia through metabolic remodeling.
• Contributes to host-microbe interactions in autism spectrum disorder via microbial macromolecules.
• Is a target of autophagy-mediated targeted protein degradation, connecting synthesis to turnover.
• Is relevant to skin aging and percutaneous drug absorption through extracellular matrix macromolecules.
• Is a common enrichment term in transcriptomic and proteomic studies of growth and proliferation [1,4].
What Happens During macromolecule biosynthetic process?
Precursor activation and monomer supply
In simple terms: Before a cell can build a macromolecule, it must first make and activate the small building blocks.
Macromolecule biosynthesis begins with the generation of activated precursors. For proteins, this means amino acids charged onto tRNA; for nucleic acids, nucleoside triphosphates; for polysaccharides, activated sugars such as UDP-sugars. Metabolic analysis of sarcopenic muscle identifies positive modulators of longevity and healthspan in C. elegans, highlighting that precursor supply and macromolecule biosynthesis are tightly coupled to organismal metabolism and aging. A hypomorphic Mpi mutation unlocks an in vivo tool for studying global N-glycosylation deficiency, illustrating how mutations in precursor pathways affect macromolecule biosynthesis and glycosylation.
Polymerization by template-dependent and template-independent mechanisms
In simple terms: The cell then strings the building blocks together, either by copying a template or by assembling them directly.
Polymerization is the central step of macromolecule biosynthetic process. Template-dependent mechanisms include DNA replication and transcription, while translation uses mRNA as a template to direct polypeptide synthesis. Template-independent mechanisms include polysaccharide biosynthesis and some cell-wall polymers. Functional taxonomy of bacterial hyperstructures describes how these biosynthetic machineries are organized into higher-order assemblies in bacteria, linking macromolecule biosynthesis to spatial organization. Macromolecule-assisted de novo protein folding further shows that the polypeptide product can be stabilized by macromolecular scaffolds during and after synthesis.
Folding, modification, and quality control
In simple terms: Once the chain is made, it must fold correctly and receive chemical decorations to become functional.
Nascent macromolecules undergo folding, modification, and quality control. Macromolecule-assisted de novo protein folding demonstrates that macromolecules can assist newly synthesized proteins in reaching their native state. Glycosylation is a major modification of proteins and lipids, and a hypomorphic Mpi mutation unlocks an in vivo tool for studying global N-glycosylation deficiency, directly linking macromolecule biosynthesis to glycosylation capacity. Autophagy-mediated targeted protein degradation provides a complementary quality-control route that removes damaged or excess macromolecules, balancing biosynthesis with turnover.
Assembly into supramolecular structures and export
In simple terms: Finished macromolecules are often assembled into larger machines or shipped to where the cell needs them.
Many macromolecules are not functional in isolation but must be assembled into supramolecular structures or exported. Functional taxonomy of bacterial hyperstructures describes how biosynthetic enzymes and their products form hyperstructures that organize cellular functions. Mechanisms of receptor-mediated transcytosis at the blood-brain barrier illustrate how macromolecules are transported across cellular barriers, a process that depends on the biosynthesis and trafficking of receptors and cargo. Skin aging modulates percutaneous drug absorption, reflecting how extracellular matrix macromolecules and barrier lipids change with age and affect transport.
Integration with cellular growth and stress programs
In simple terms: The cell adjusts how much macromolecule it makes depending on nutrients, stress, and growth signals.
Macromolecule biosynthetic process is integrated with growth and stress signaling. Metabolic analysis of sarcopenic muscle identifies positive modulators of longevity and healthspan in C. elegans, showing that biosynthetic and metabolic programs are coordinated with longevity pathways. Integrative multi-omics analysis of autism spectrum disorder reveals unique microbial macromolecules interactions, indicating that host-microbe macromolecule exchange can influence neurodevelopmental biology. Autophagy-mediated targeted protein degradation further connects biosynthetic output to degradation capacity, ensuring proteome homeostasis.
Key Genes Involved in GO:0009059 macromolecule biosynthetic process
The following genes and proteins are representative components, regulators, or modifiers of macromolecule biosynthetic process across model systems and human biology, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MPI | Mannose-6-phosphate isomerase in N-glycosylation precursor supply | Hypomorphic Mpi mutation provides an in vivo tool for global N-glycosylation deficiency |
| RPTOR | Regulatory-associated protein of mTOR complex 1 | mTORC1 controls translation and macromolecule biosynthesis in growth and aging |
| MTOR | Mechanistic target of rapamycin kinase | Central regulator of translation, ribosome biogenesis, and macromolecule biosynthesis |
| RPS6KB1 | Ribosomal protein S6 kinase B1 | Downstream effector of mTORC1 that promotes translation initiation |
| EIF4EBP1 | Eukaryotic translation initiation factor 4E binding protein 1 | Represses cap-dependent translation when hypophosphorylated |
| MAP1LC3B | Microtubule-associated protein 1 light chain 3 beta | Autophagy marker linking macromolecule turnover to biosynthesis |
| SQSTM1 | Sequestosome 1 / p62 | Autophagy receptor involved in targeted protein degradation |
| BECN1 | Beclin 1 | Core autophagy regulator that balances biosynthesis and degradation |
| HSPA1A | Heat shock protein family A member 1A | Chaperone supporting folding of newly synthesized macromolecules |
| HSP90AA1 | Heat shock protein 90 alpha family class A member 1 | Chaperone assisting folding and maturation of client proteins |
| CANX | Calnexin | ER chaperone for glycoprotein folding and quality control [5,8] |
| CALR | Calreticulin | ER chaperone for glycoprotein folding and quality control [5,8] |
| UGGT1 | UDP-glucose glycoprotein glucosyltransferase 1 | Glycoprotein folding sensor in the ER |
| GANAB | Glucosidase II alpha subunit | N-glycan processing enzyme in the ER |
| INSR | Insulin receptor | Receptor-mediated signaling that promotes macromolecule biosynthesis |
| LRP1 | LDL receptor related protein 1 | Receptor-mediated transcytosis of macromolecules at the blood-brain barrier |
| TFRC | Transferrin receptor | Model receptor for receptor-mediated transcytosis of macromolecules |
How Is macromolecule biosynthetic process Regulated?
Macromolecule biosynthetic process is regulated at multiple levels. Nutrient-sensing pathways, especially mTORC1, control translation initiation and ribosome biogenesis, and metabolic analysis of sarcopenic muscle identifies positive modulators of longevity and healthspan in C. elegans, showing that these biosynthetic programs are coordinated with longevity signaling. Autophagy-mediated targeted protein degradation provides a counterbalancing degradation arm, so that biosynthetic output is matched to proteome needs. Glycosylation capacity is regulated by precursor supply, as illustrated by a hypomorphic Mpi mutation that unlocks an in vivo tool for studying global N-glycosylation deficiency. In bacteria, functional taxonomy of bacterial hyperstructures describes how biosynthetic enzymes are spatially organized into hyperstructures that influence pathway efficiency. Finally, macromolecule-assisted de novo protein folding indicates that folding capacity itself can feed back on biosynthetic flux.
macromolecule biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MPI | Global N-glycosylation deficiency | Hypomorphic Mpi knock-in mouse or cell line |
| MTOR | Sarcopenia and age-related metabolic decline | Muscle-specific mTOR knockout or point-mutation models |
| MAP1LC3B | Proteostasis and autophagy-related disease | LC3B knockout or tagged knock-in for flux measurement |
| LRP1 | Blood-brain barrier macromolecule transport | LRP1 knockout and knock-in for transcytosis assays |
| TFRC | Receptor-mediated transcytosis and drug delivery | TFRC knockout and tagged knock-in models |
Congenital disorders of glycosylation and N-glycosylation deficiency
Macromolecule biosynthetic process is directly linked to glycosylation disorders. A hypomorphic Mpi mutation unlocks an in vivo tool for studying global N-glycosylation deficiency, demonstrating that impaired precursor supply for N-glycan biosynthesis causes systemic glycosylation defects. Because glycosylation is a major macromolecule modification, defects in this branch of macromolecule biosynthesis affect protein folding, trafficking, and function, and they can present as multisystem disease [5,8].
Sarcopenia, aging, and metabolic decline
Age-related loss of muscle mass and function is associated with altered macromolecule biosynthesis and metabolism. Metabolic analysis of sarcopenic muscle identifies positive modulators of longevity and healthspan in C. elegans, linking muscle metabolic remodeling to conserved longevity pathways that govern biosynthetic investment. Skin aging modulates percutaneous drug absorption, showing that age-related changes in extracellular matrix macromolecules and barrier properties affect how drugs cross the skin. Together, these findings place macromolecule biosynthetic process at the interface of aging, tissue maintenance, and pharmacology [2,4].
Neurodevelopmental and host-microbe interactions
Integrative multi-omics analysis of autism spectrum disorder reveals unique microbial macromolecules interactions, suggesting that microbial macromolecules and host biosynthetic pathways may interact in neurodevelopmental conditions. Mechanisms of receptor-mediated transcytosis at the blood-brain barrier describe how macromolecules cross the BBB, a process relevant to delivering therapeutics and to understanding how circulating macromolecules influence the brain. These studies highlight that macromolecule biosynthetic process and macromolecule transport are intertwined in brain health and disease [1,6].
Protein quality control, autophagy, and degradation balance
Imbalances between macromolecule biosynthesis and degradation contribute to disease. Autophagy-mediated targeted protein degradation describes how cells remove proteins and other macromolecules through autophagy, providing a counterweight to biosynthesis. Macromolecule-assisted de novo protein folding shows that folding assistants can stabilize newly synthesized polypeptides, and failure of this quality-control system can lead to aggregation and dysfunction. Thus, diseases of proteostasis often reflect a mismatch between macromolecule biosynthetic process and degradation capacity [3,8].
From macromolecule biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene control macromolecule biosynthesis rate? | CRISPR knockout followed by metabolic labeling and proteomics [3,4] |
| Does a specific point mutation alter biosynthetic enzyme activity? | CRISPR point-mutation knock-in of the catalytic residue |
| Where and when is a biosynthetic protein expressed? | Endogenous tagged knock-in with fluorescent or epitope tag |
| Does overexpression of a biosynthetic regulator increase output? | CRISPR overexpression or cDNA overexpression model |
| Which genes are required for glycosylation-dependent biosynthesis? | Genome-wide CRISPR library screening with glycan readouts |
| How does a disease variant affect macromolecule transport? | Patient-derived iPSC knockout and isogenic knock-in |
How to Study the macromolecule biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Stable-isotope metabolic labeling | Rate of precursor incorporation into macromolecules | Quantifying macromolecule biosynthetic flux |
| RNA sequencing | Transcript levels of biosynthetic genes | Pathway enrichment and candidate discovery |
| Multi-omics integration | Host-microbe macromolecule interactions | Microbiome-host studies in neurodevelopmental disorders |
| Mass spectrometry proteomics | Protein abundance and modifications | Proteome-wide biosynthetic output [5,8] |
| Glycomics | N-glycan structures and occupancy | Glycosylation deficiency models |
| Fluorescent tagging and imaging | Localization and dynamics of biosynthetic proteins | Live-cell studies of synthesis and transport [3,6] |
| Autophagy flux assays | Degradation of macromolecules | Proteostasis and turnover studies |
| CRISPR library screening | Genes required for a biosynthetic phenotype | Functional genomics of macromolecule biosynthesis |
Metabolic labeling and flux analysis
Metabolic labeling with stable-isotope precursors measures the rate at which cells incorporate low-molecular-mass units into macromolecules. This approach is well suited to quantifying macromolecule biosynthetic process and has been applied in metabolic analysis of sarcopenic muscle to identify modulators of longevity and healthspan in C. elegans. Combining labeling with mass spectrometry allows precursor supply and polymerization to be distinguished.
Transcriptomics and multi-omics
RNA sequencing and integrative multi-omics can reveal coordinated expression of biosynthetic genes. Integrative multi-omics analysis of autism spectrum disorder reveals unique microbial macromolecules interactions, demonstrating how multi-omics can uncover host-microbe macromolecule relationships. Enrichment of GO:0009059 in such datasets indicates active biopolymer production [1,7].
Proteomics and glycomics
Mass-spectrometry-based proteomics and glycomics quantify the products of macromolecule biosynthesis and their modifications. A hypomorphic Mpi mutation unlocks an in vivo tool for studying global N-glycosylation deficiency, and glycomic profiling is central to characterizing such defects. Proteomics also detects changes in chaperones and folding enzymes that support macromolecule biosynthesis.
Imaging and reporter assays
Fluorescent reporters, tagged knock-ins, and live-cell imaging visualize where and when macromolecules are synthesized. Autophagy-mediated targeted protein degradation uses tagged reporters to monitor turnover, complementing biosynthetic measurements. Receptor-mediated transcytosis at the blood-brain barrier can be imaged with labeled macromolecule cargos to study transport.
How CRISPR Can Be Used to Study GO:0009059 macromolecule biosynthetic process
Knockout
CRISPR knockout is used to delete genes annotated to macromolecule biosynthetic process and test whether they are required for biopolymer production. For example, knocking out autophagy genes such as MAP1LC3B or BECN1 reveals how degradation pathways intersect with biosynthesis. Knockout of metabolic regulators such as MTOR or RPTOR can be used to probe growth-dependent biosynthetic programs.
Point Mutation
Point-mutation knock-in allows precise testing of catalytic residues, phosphorylation sites, and disease variants in biosynthetic enzymes. A hypomorphic Mpi mutation unlocks an in vivo tool for studying global N-glycosylation deficiency, illustrating how a single-nucleotide change can tune macromolecule biosynthesis. Point mutations in mTOR substrates can dissect signaling arms that control translation.
Knock-in
Knock-in of tags, reporters, or humanized alleles enables tracking and functional analysis of macromolecule biosynthetic machinery. Endogenous tagging of LC3B or SQSTM1 supports autophagy flux measurement. Knock-in of disease-relevant variants in glycosylation genes can model congenital disorders of glycosylation.
Overexpression
CRISPR activation or cDNA overexpression is used to increase the dosage of biosynthetic regulators and test sufficiency. Overexpression of growth-promoting factors can enhance macromolecule biosynthesis, while overexpression of chaperones such as HSPA1A or HSP90AA1 can improve folding capacity. Overexpression models are also useful for testing whether a candidate gene drives biosynthetic output in disease contexts.
How EDITGENE Supports macromolecule biosynthetic process Research
Researchers studying macromolecule biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in biopolymer production, how a specific variant alters enzyme activity, or where the encoded protein acts within the cell. Answering these questions requires precise, isogenic models that isolate the gene of interest from background variation. EDITGENE provides end-to-end CRISPR services designed for this purpose, from knockout and point-mutation cell lines to knock-in reporters, overexpression models, and genome-wide library screening with bioinformatics support [3,4,5].
Contact EDITGENE today to design your custom CRISPR model for macromolecule biosynthetic process research.
Frequently Asked Questions About macromolecule biosynthetic process
What is GO:0009059 macromolecule biosynthetic process?
GO:0009059 is a Gene Ontology biological-process term describing the chemical reactions and pathways that form macromolecules, which are high-molecular-mass molecules built from repeated low-molecular-mass units.
What genes are involved in macromolecule biosynthetic process?
Genes involved include metabolic regulators such as MTOR and RPTOR, glycosylation enzymes such as MPI, autophagy proteins such as MAP1LC3B and SQSTM1, and chaperones such as HSPA1A and HSP90AA1 [3,4,5,8].
What are the synonyms of macromolecule biosynthetic process?
Synonyms include biopolymer biosynthetic process, macromolecule anabolism, macromolecule biosynthesis, macromolecule formation, and macromolecule synthesis.
Why is macromolecule biosynthetic process important for cells?
It supplies the proteins, nucleic acids, and polysaccharides required for growth, division, structure, and information storage, and it consumes a large share of cellular energy [4,7].
How is macromolecule biosynthetic process regulated?
It is regulated by nutrient-sensing pathways such as mTORC1, by autophagy-mediated degradation, by precursor supply, and by folding capacity in the endoplasmic reticulum [3,4,5,8].
What diseases are linked to defects in macromolecule biosynthesis?
Defects are linked to congenital disorders of glycosylation, sarcopenia and age-related metabolic decline, neurodevelopmental conditions with host-microbe interactions, and proteostasis disorders [1,3,4,5].
How can CRISPR be used to study macromolecule biosynthetic process?
CRISPR knockout, point mutation, knock-in, and overexpression allow causal testing of genes that build or regulate macromolecules, while library screening identifies required factors at scale [3,4,5].
What methods measure macromolecule biosynthetic process?
Stable-isotope metabolic labeling, RNA sequencing, multi-omics, proteomics, glycomics, imaging, autophagy flux assays, and CRISPR screens are commonly used [1,3,4,5,6,8].
What is the difference between macromolecule biosynthetic process and translation?
Translation is one child process of macromolecule biosynthetic process; the parent term also includes nucleic acid and polysaccharide biosynthesis.
Which model systems are used to study macromolecule biosynthetic process?
Common models include C. elegans for longevity and metabolism, mouse and cell lines for glycosylation and signaling, and patient-derived iPSCs for disease variants [4,5,6].
Conclusion
GO:0009059 macromolecule biosynthetic process is a foundational Gene Ontology term that unifies the anabolic pathways producing proteins, nucleic acids, polysaccharides, and other biopolymers. Its breadth makes it a powerful annotation for interpreting omics data, while its mechanistic depth connects precursor supply, polymerization, folding, modification, and quality control [3,4,5,7,8]. From glycosylation disorders and sarcopenia to neurodevelopmental host-microbe interactions and proteostasis, defects in macromolecule biosynthesis have broad disease relevance [1,3,4,5]. CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with metabolic labeling, multi-omics, and imaging, provide the tools needed to dissect these pathways with causal precision [3,4,5,6].
References
- 1. Osama A et al.. 2025. Integrative multi-omics analysis of autism spectrum disorder reveals unique microbial macromolecules interactions.. J Adv Res 77:265-279 PMID: 39870302
- 2. Hung CF et al.. 2015. Skin aging modulates percutaneous drug absorption: the impact of ultraviolet irradiation and ovariectomy.. Age (Dordr) 37(2):21 PMID: 25721687
- 3. Shao J et al.. 2025. Autophagy-Mediated Targeted Protein Degradation.. ChemMedChem 20(6):e202400866 PMID: 39672806
- 4. Jonk SM et al.. 2025. Metabolic analysis of sarcopenic muscle identifies positive modulators of longevity and healthspan in C. elegans.. Redox Biol 85:103732 PMID: 40544604
- 5. Lin EB et al.. 2025. A hypomorphic Mpi mutation unlocks an in vivo tool for studying global N-glycosylation deficiency.. JCI Insight 10(14) PMID: 40693465
- 6. Baghirov H. 2025. Mechanisms of receptor-mediated transcytosis at the blood-brain barrier.. J Control Release 381:113595 PMID: 40056994
- 7. Norris V et al.. 2007. Functional taxonomy of bacterial hyperstructures.. Microbiol Mol Biol Rev 71(1):230-53 PMID: 17347523
- 8. Choi SI et al.. 2012. Macromolecule-assisted de novo protein folding.. Int J Mol Sci 13(8):10368-10386 PMID: 22949867
